[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30. DOI:10.3322/caac.21442.
[2] Cong XU, Cao K, Liu L, et al. Advances in sensitive biomarkers of radiotherapy in colorectal cancer patients[J]. J Transl Med, 2017, 4(9):84-87. DOI:10.3969/j.issn.2095-6894.2017.09.020.
[3] 储小飞, 赵舒怡, 樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志, 2015, 39(5):431-436. DOI:10.3760/cma.j.issn.1673-4114.2015.05.019.
Chu XF, Zhao SY, Fan SJ. Advance progress of cancer stem cells and radioresistance[J]. Int J Radiat Med Nucl Med, 2015, 39(5):431-436.  doi: 10.3760/cma.j.issn.1673-4114.2015.05.019
[4] 杨丽君, 万晓晨.结直肠癌中miR-106b增强肿瘤细胞放疗抵抗作用机制的初步分析[J].中国现代医生, 2018, 56(1):29-31, 35.
Yang LY, Wan XC. Preliminary analysis on the mechanism of miR-106b enhancing the radioresistance of tumor cells in colorectal cancer[J]. Chin Mod Doctor, 2018, 56(1):29-31, 35.
[5] Clough E, Barrett T. The Gene Expression Omnibus Database[J]. Methods Mol Biol, 2016, 1418:93-110. DOI:10.1007/978-1-4939-3578-9_5.
[6] He X, Fan L, Wu Z, et al. Gene expression profiles reveal key pathways and genes associated with neuropathic pain in patients with spinal cord injury[J]. Mol Med Rep, 2017, 15(4):2120-2128. DOI:10.3892/mmr.2017.6231.
[7] Keerin P, Kurutach W, Boongoen T. Cluster-based KNN missing value imputation for DNA microarray data[J]. Int J Data Min Bioinform, 2012, 15(2):445-450. DOI:10.1109/ICSMC.2012. 6377764.
[8] Liew AW, Law NF, Yan H. Missing value imputation for gene expression data:computational techniques to recover missing data from available information[J]. Brief Bioinform, 2011, 12(5):498-513. DOI:10.1093/bib/bbq080.
[9]

Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies[J/OL]. Nucleic Acids Res, 2015, 43(7): e47[2018-05-02]. https: //www. ncbi. nlm. nih. gov/pubmed/25605792. DOI: 10.1093/nar/gkv007.
[10] Peri S, Navarro JD, Amanchy R, et al. Development of human protein reference database as an initial platform for approaching systems biology in humans[J]. Genome Res, 2003, 13(10):2363-2371. DOI:10.1101/gr.1680803.
[11] Smoot ME, Ono K, Ruscheinski J, et al. Cytoscape 2.8:new features for data integration and network visualization[J]. Bioinformatics, 2011, 27(3):431-432. DOI:10.1093/bioinformatics/btq675.
[12] Shannon P, Markiel A, Ozier O, et al. Cytoscape:a software environment for integrated models of biomolecular interaction networks[J]. Genome Res, 2003, 13(11):2498-2504. DOI:10.1101/gr.1239303.
[13] Lin CY, Chin CH, Wu HH, et al. Hubba:hub objects analyzer-a framework of interactome hubs identification for network biology[J]. Nucleic Acids Res, 2008, 36(Web Server issue):W438-W443. DOI:10.1093/nar/gkn257.
[14] Cline MS, Smoot M, Cerami E, et al. Integration of biological networks and gene expression data using Cytoscape[J]. Nat Pro, 2007, 2(10):2366-2382. DOI:10.1038/nprot.2007.324.
[15] Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data[J]. Biostatistics, 2003, 4(2):249-264. DOI:10.1093/biostatistics/4.2.249.
[16] Jeong H, Mason SP, Barabási AL, et al. Lethality and centrality in protein networks[J]. Nature, 2001, 411(6833):41-42. DOI:10.1038/35075138.
[17]

Goh KI, Oh E, Kahng B, et al. Betweenness centrality correlation in social networks[J/OL]. Phys Rev E Stat Nonlin Soft Matter Phys, 2003, 67(1 Pt 2): 017101[2018-05-02]. https: //www. ncbi. nlm. nih. gov/pubmed/12636633. DOI: 10.1103/PhysRevE.67.017101.
[18] Ronnekleiv-Kelly SM, Burkhart RA, Pawlik TM. Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer[J]. Surg Oncol, 2016, 25(3):190-199. DOI:10.1016/j.suronc.2016. 05.018.
[19] Leroi N, Lallemand F, Coucke P, et al. Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment[J]. Front Pharmacol, 2016, 7:78. DOI:10.3389/fphar.2016.00078.
[20] Moncharmont C, Levy A, Guy JB, et al. Radiation-enhanced cell migration/invasion process:a review[J]. Crit Rev Oncol Hematol, 2014, 92(2):133-142. DOI:10.1016/j.critrevonc.2014.05.006.
[21] Basu AK. DNA damage, mutagenesis and cancer[J]. Int J Mol Sci, 2018, 19(4):970-970. DOI:10.3390/ijms19040970.
[22] Lee SY, Jeong EK, Ju MK, et al. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation[J]. Mol Cancer, 2017, 16(1):10. DOI:10.1186/s12943-016-0577-4.
[23] Sharma A, Mendonca J, Ying J, et al. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion[J]. Mol Oncol, 2017, 11(6):655-669. DOI:10.1002/1878-0261.12059.
[24] Ma J, Gao Q, Zeng S, et al. Knockdown of NDRG1 promote epithelial-mesenchymal transition of colorectal cancer via NF-κB signaling[J]. J Surg Oncol, 2016, 114(4):520-527. DOI:10.1002/jso.24348.
[25] Agarwal S, Ghosh R, Chen Z, et al. Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma[J]. Oncotarget, 2016, 7(17):24018-24026. DOI:10.18632/oncotarget.8116.
[26] Ke Q, Wu J, Ming B, et al. Identification of the PAG1 gene as a novel target of inherent radioresistance in human laryngeal carcinoma cells[J]. Cancer Biother Radiopharm, 2012, 27(10):678-684. DOI:10.1089/cbr.2012.1191.
[27] Wang C, Li P, Xuan J, et al. Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation[J]. Cell Physiol Biochem, 2017, 42(2):729-742. DOI:10.1159/000477890.
[28] Lillis AP, Van Duyn LB, Murphy-Ullrich JE, et al. LDL receptor-related protein 1:unique tissue-specific functions revealed by selective gene knockout studies[J]. Physiol Rev, 2008, 88(3):887-918. DOI:10.1152/physrev.00033.2007.
[29] Li Y, Reynolds RC. LRP1:a tumor and metastasis promoter or suppressor?[J]. Biochem Pharmacol, 2012, 1(5):121. DOI:10.4172/2167-0501.1000e121.
[30] Xu J, Zhang T, Wang T, et al. PIM kinases:an overview in tumors and recent advances in pancreatic cancer[J]. Future Oncol, 2014, 10(5):865-876. DOI:10.2217/fon.13.229.
[31] Zemskova M, Sahakian E, Bashkirova S, et al. The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells[J]. J Biol Chem, 2008, 283(30):20635-20644. DOI:10.1074/jbc.M709479200.
[32] Gu H, Liu M, Ding C, et al. Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1[J]. Cancer Med, 2016, 5(6):1174-1182. DOI:10.1002/cam4.664.
[33] Blasi F, Carmeliet P. uPAR:a versatile signalling orchestrator[J]. Nat Rev Mol Cell Biol, 2002, 3(12):932-943. DOI:10.1038/nrm977.
[34] Foekens JA, Peters HA, Look MP, et al. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients[J]. Cancer Res, 2000, 60(3):636-643.